Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Prospective Outcomes of Second Line Therapy in Acute Gvhd: Six Month Freedom from Treatment Failure and Day 28 Response in a Multicentre Study

Rohini Radia, MD FRCPath, Arun Alfred, Matthew P. Collin, MD PhD, Maria H Gilleece, MD FRCPath, MB, BSc, FRCP, James E Griffin, BSc (Hons), MBChB (Hons), PhD, Ann E. Hunter, MBBS, FRCP, FRCPath, Hannah Hunter, MB, FRCPath, MRCP, Harpreet Kaur, Nandita Khera, MD, Kavita Raj, MD PhD, Emma Das-Gupta, DM, FRCPath, MRCP, Fiona Louise Dignan, MD, Madan Jagasia, MD MS

Blood (2018) 132 (Supplement 1): 3408.

https://doi.org/10.1182/blood-2018-99-115376

Published: 2018

Journal Articles

Extracorporeal Photopheresis As Second Line Therapy for Steroid Refractory Acute Gvhd: Retrospective Study of Long-Term Outcomes

Rohini Radia, MBChB, Emma Das-Gupta, MD, Guillermo Orti, MD, Donal McLornan, MDPhD, Majid A. Kazmi, Christopher P Fox, PhD, Jenny L. Byrne, PhD, Nigel H. Russell, MD, Kavita Raj, MDPhD

Blood (2015) 126 (23): 1944.

https://doi.org/10.1182/blood.V126.23.1944.1944

Published: 2015

Journal Articles

A Multicentre Retrospective UK Study Detailing Onset Of Graft Verus Host Disease, Responses To Treatment and Outcome After Donor Lymphocyte Infusion Following Haemopoietic Stem Cell Transpantation: Rates Of GVHD Are High But Death From GVHD Infrequent

Julia J Scarisbrick, MBhons ChB FRCP MD, Fiona L Dignan, Sameer Tulpule, Emma Das gupta, Gulnaz Shah, Antonio Pagliuca, Ram Malladi, Kavita Raj, MD, PhD, MRCP, FRCPath

Blood (2013) 122 (21): 4645.

https://doi.org/10.1182/blood.V122.21.4645.4645

Published: 2013

Journal Articles

Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation

David Burns, Shabeeha Rana, Andrew Howman, Sandeep Nagra, Janice Ward, Husam Osman, Yusri Taha, Jenny Byrne, Emma Das-Gupta, Manoj Raghavan, Ram Malladi, Mark Cook, Prem Mahendra, Nigel H. Russell, MD, Charles Craddock, Christopher Fox, Sridhar Chaganti

Blood (2012) 120 (21): 460.

https://doi.org/10.1182/blood.V120.21.460.460

Published: 2012

Journal Articles

Extracorporeal Photopheresis (ECP): Effective Therapy for Steroid Dependent and Refractory Acute Graft-Versus-Host Disease (GVHD)

Ryan W Jacobs, MD, Madan H. Jagasia, MD, Bipin N. Savani, MD, Anne T. Neff, MD, Adetola A. Kassim, MD, MS, Brian Engelhardt, MD, Stacey Goodman, MD, John P Greer, MD, Karen Proctor, RN, Friedrich Schuening, MD, Nigel H. Russell, MD, Emma Das-Gupta, DM, FRCPath, MRCP

Blood (2011) 118 (21): 1973.

https://doi.org/10.1182/blood.V118.21.1973.1973

Published: 2011

Journal Articles

Results of a Prospective Clinical Trial of Pre-DLI Lymphoreduction Using Oral Fludarabine In Patients with Mixed Chimerism Post Allogeneic Transplant.

Bronwen E. Shaw, PhD, MRCP, FRCPath, Jenny Byrne, MD, PhD, Emma Das-Gupta, DM, FRCPath, MRCP, Mark Ethell, MA, MBBChir, MRCP, FRCPath, Daniel Figueroa, J. Alejandro Madrigal, MD, PhD, Gareth J Morgan, MD, PhD, Sameer Tulpule, MBBS, MD, MRCP, Michael Potter, MA, MB, Phd, FRCP, (UK), FRCPath, Nigel H. Russell, MD

Blood (2010) 116 (21): 1299.

https://doi.org/10.1182/blood.V116.21.1299.1299

Published: 2010

Journal Articles

Interactions of Midostaurin (PKC412), Rapamycin and Ara-C in AML Cell Lines: Role of FLT3 Signalling.

Claire H. Seedhouse, PhD, Shili Shang, MSc, Nigel Russell, MD, Emma Das-Gupta, MD

Blood (2007) 110 (11): 2841.

https://doi.org/10.1182/blood.V110.11.2841.2841

Published: 2007

Journal Articles

Factors Predicting Long Term Survival after Reduced Intensity Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia.

Charles F. Craddock, MD, PhD, Sudhir Tauro, MDPhD, Joanne E. Gregory, Laura Buckley, PhD, Janice Ward, BSc(Hons), Panos Kottaridis, MDPhD, Eleni Thelouli, MDPhD, Kirsty Thomson, MDPhD, Donald Milligan, MDPhD, Emma Das-Gupta, MDPhD, Effie Liakpopoulou, MDPhD, John Snowden, MDPhD, John Yin, MDPhD, Andrew Peniket, MDPhD, Mark Cook, MDPhD, Stephen MacKinnon, MDPhD, Nigel H. Russell, MDPhD

Blood (2007) 110 (11): 326.

https://doi.org/10.1182/blood.V110.11.326.326

Published: 2007

Journal Articles

Low Pre-DLI Lymphocytes Counts Are Predictive of Good Disease Responses in Patients with Mixed Chimerism Following Campath-Containing Reduced Intensity Transplants.

Bronwen E. Shaw, MRCPath, PhD, Jenny L. Byrne, MRCPath, PhD, Emma Das-Gupta, MRCP, PHD, Ian Carter, PhD, Nigel H. Russell

Blood (2006) 108 (11): 261.

https://doi.org/10.1182/blood.V108.11.261.261

Published: 2006

Journal Articles

Converting Mixed Chimerism to Full Donor Chimerism in Recipients of Campath-Containing Reduced Intensity Transplants Reduces the Relapse Risk and Results in Significantly Improved Survival Compared to Those with Persistent Full Donor Chimerism.

Bronwen E. Shaw, MRCP, PhD, Jenny L. Byrne, MRCP, PhD, Emma Das-Gupta, MRCP, PhD, Ian Carter, PhD, Nigel H. Russell, FRCPath, PhD

Blood (2005) 106 (11): 2026.

https://doi.org/10.1182/blood.V106.11.2026.2026

Published: 2005

Journal Articles

The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia

Claire Seedhouse, Rowena Bainton, Michael Lewis, Alexander Harding, Nigel Russell, Emma Das-Gupta

Blood (2002) 100 (10): 3761–3766.

https://doi.org/10.1182/blood-2002-04-1152

Published: 2002

NARROW

Prospective Outcomes of Second Line Therapy in Acute Gvhd: Six Month Freedom from Treatment Failure and Day 28 Response in a Multicentre Study

Extracorporeal Photopheresis As Second Line Therapy for Steroid Refractory Acute Gvhd: Retrospective Study of Long-Term Outcomes

A Multicentre Retrospective UK Study Detailing Onset Of Graft Verus Host Disease, Responses To Treatment and Outcome After Donor Lymphocyte Infusion Following Haemopoietic Stem Cell Transpantation: Rates Of GVHD Are High But Death From GVHD Infrequent

Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation

Extracorporeal Photopheresis (ECP): Effective Therapy for Steroid Dependent and Refractory Acute Graft-Versus-Host Disease (GVHD)

Results of a Prospective Clinical Trial of Pre-DLI Lymphoreduction Using Oral Fludarabine In Patients with Mixed Chimerism Post Allogeneic Transplant.

Interactions of Midostaurin (PKC412), Rapamycin and Ara-C in AML Cell Lines: Role of FLT3 Signalling.

Factors Predicting Long Term Survival after Reduced Intensity Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia.

Low Pre-DLI Lymphocytes Counts Are Predictive of Good Disease Responses in Patients with Mixed Chimerism Following Campath-Containing Reduced Intensity Transplants.

Converting Mixed Chimerism to Full Donor Chimerism in Recipients of Campath-Containing Reduced Intensity Transplants Reduces the Relapse Risk and Results in Significantly Improved Survival Compared to Those with Persistent Full Donor Chimerism.

The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only